Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients: a systematic review and meta-analysis

BACKGROUND: Anti-epidermal growth factor receptor (EGFR)-monoclonal antibodies (MoAbs) have been widely used in a variety of malignancies. Severe infections (≥grade 3) are potentially life-threatening adverse events with these drugs. However, the contribution of anti-EGFR MoAbs to infections is stil...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Med
Hlavní autoři: Qi, Wei-Xiang, Fu, Shen, Zhang, Qing, Guo, Xiao-Mao
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4236487/
https://ncbi.nlm.nih.gov/pubmed/25369798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-014-0203-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky